Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® PrEP specialty page provides PrEP-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

PREP NEWS - Page 1

Adolescent HIV Prevention: Overcoming the PrEP
Conversations about PrEP with a clinician are the least common among adolescents with the greatest risk for HIV.
Examining HIV Training Pathways in Residency
HIV training pathways in residency have added 90 HIV physicians to the workforce since 2006.
Ending the HIV Epidemic Initiative: A Snapshot From the Trenches, 1 Year Later
Funded jurisdictions scramble to meet daunting deadlines yet maintain optimism that the new federal initiative can end flat funding and catalyze progress.
PrEP Coverage Associated with Decreased HIV Diagnoses
HIV pre-exposure prophylaxis appears to be making a difference, according to new research, which showed an association between increases in PrEP coverage and decreases in HIV diagnosis rates in the United States.
Kenneth Mayer, MD: Reasons for Suboptimal PrEP Use Among At-Risk US MSM
A new study examining the reasons for suboptimal PrEP use among MSM was presented at CROI 2020.
Onyema Ogbuagu, MD: DISCOVER Week 96 Results
Contagion® spoke to Onyema Ogbuagu, MD, who presented the week 96 results from the DISCOVER study evaluating F/TAF and F/TDF.
DISCOVER 96 Week Results Back F/TAF Efficacy
There was a statistically significant difference in renal safety which favored F/TAF over F/TDF at Week 96.
Cabotegravir and Rilpivirine Maintains Efficacy in FLAIR 96-Week Data
New Week 96 data from the FLAIR study indicate that once-monthly injections of cabotegravir and rilpivirine remains non-inferior and safe when compared with the daily, oral 3-drug regimen of ABC/DTG/3TC.
 
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?